DBU - Medical ELISA

SD Standard E Dengue IgG Elisa Analyzes Test Kit

Standard E Dengue Elisa Analyzes IgM Test Kit

Standard E Dengue NS1 Elisa Analyzes Test Kit

Panbio Dengue IgM Capture ELISA

Panbio Leptospira IgM Elisa

Panbio DENGUE Ig CAPTURE ELISA

Panbio DENGUE EARLY ELISA

RecombiLISA Dengue Ag ELISA Kit

TRUSTwell CHIK IgM ELISA Kit

TRUSTwell HBsAg ELISA Kit

TRUSTwell HIV Ag-Ab ELISA Kit

TRUSTwell HIV 1 2 Ab ELISA Kit

TRUSTwell Dengue IgG ELISA Kit

Scrub Typhus Detect IgG ELISA System

CHIKjj Detect IgG ELISA Kit

Filaria Detect IgG4 ELISA

ZIKV Detect 2.0 IgM Capture ELISA

Bioline DENGUE NS1 Ag ELISA

RecombiLISA HAV IgM ELISA Kit

RecombiLISA Total T3 Elisa Kit

RecombiLISA Total T4 ELISA Kit

RecombiLISA TSH ELISA kit

RecombiLISA Leptospira IgM ELISA Kit

TRUSTwell Dengue IgM ELISA Kit

TRUSTwell Syphilis Ab kit

TRUSTwell HCV IgG ELISA Kit

STANDARD E TB-Feron Tubes 200

STANDARD E TB-Feron Tubes 300

J Mitra ELISA Reader

J Mitra ELISA Washer

DENV Detect NS1 ELISA

The DENV Detect NS1 ELISA is for the early detection of Dengue virus (DENV) NS1 antigen in human serum. This test is for the presumptive clinical laboratory diagnosis of Dengue virus infection. This assay is intended for use in patients with clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. Samples collected from patients within seven (7) days after the onset of clinical symptoms should be evaluated with this assay (day 0 day 7). Negative results obtained with this test do not preclude the diagnosis of dengue and should not be used as the sole basis for treatment or other patient management decision. This assay is not FDA cleared or approved for testing blood or plasma donors. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. FDA Cleared & CE Marked Early NS1 antigen detection (within first 7 days onset of symptoms) Helps differentiate dengue from other flaviviruses that may cross react with dengue antibodies but not with the antigen High Sensitivity & Specificity: 86.6% PPA & 97.8% NPA with prospectively collected positive and negative confirmed clinical specimens Kit can be performed in parallel with InBios FDA Cleared dengue IgM ELISA for presumptive diagnosis of acute or convalescent stage dengue virus.

InBios DENV Detect IgM Capture ELISA

The DENV DetectTM IgM Capture ELISA is for the qualitative detection of IgM antibodies to DENV recombinant antigens in serum for the presumptive clinical laboratory diagnosis of Dengue virus infection. The assay is intended for use only in patients with clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. 1st Assay to Receive FDA Clearance. Performance thoroughly evaluated with clinically confirmed cases of dengue 1-4 serotypes. Excellent positive and negative agreement with WHO reference panel (>90%). Improves accuracy by monitoring background reactivity with a normal cell antigen. Employs a simple, one step ratio method of interpretation. CE Marked.

CHIKjj Detect IgM ELISA Kit

The CHIKjj Detect IgM ELISA is designed for the qualitative detection of IgM antibodies present in human serum targeting Chikungunya virus E2/E1 proteins. This test is not intended to screen blood or blood components. This test is for research use only. Not for use in diagnostic procedures. The complete kit includes one 96 well strippable plate with all necessary reagents and controls. Key Features : InBios chikungunya kits have been developed using a novel technology1 that outperforms traditional antigen preparations, resulting in highly sensitive detection of recent and past CHIKV infection. Excellent results in CDC evaluation of commercially available chikungunya IgM assays.

RecombiLISA HEV IgM ELISA Kit

INTENDED USE: The RecombiLISA HEV IgM ELISA is a solid-phase enzyme-linked immunosorbent assay for the qualitative detection of anti-hepatitis E virus (HEV) IgM in human serum or plasma. It is intended for professional use only and to be used as an aid in the diagnosis of infection with HEV. TEST PRINCIPLE: The RecombiLISA HEV IgM ELISA is a solid-phase enzyme-linked immunosorbent assay based on the principle of the IgM capture technique for the detection of antiHEV IgM in human serum or plasma. The RecombiLISA HEV IgM ELISA is composed of two key components: 1) Solid microwells pre-coated with polyclonal anti-human IgM antibody 2) Liquid conjugate composed of HEV antigen conjugated with horseradish peroxidase (HRP-HEV Conjugate) During the assay, the test specimen is first incubated in the coated microwells. AntiHEV IgM, if present in the specimen, binds to the antibody coated on the microwell surface. Any unbound specimen is then removed by a wash step. During a second incubation with the HRP-HEV Conjugate, the anti-HEV IgM antibody is absorbed on the microwell surface which binds to the HRP-HEV Conjugate, forming a conjugate complex. Unbound conjugate is then removed by washing. After addition of the TMB substrate, the presence of conjugate complex is shown by development of a blue color resulting from a reaction between the enzyme and substrate. The reaction is then quenched by addition of the Stop Solution, and the absorbance value for each microwell is determined using a spectrophotometer at 450/620-690 nm. Clinical Performance: A total of 400 specimens from susceptible subjects were tested by the RecombiLISA HEV IgM ELISA and by a Chinese State Drug Administration (SFDA) licensed reference EIA. Clinical Performance: Relative Sensitivity: 100%, Relative Specificity: 100%, Overall Agreement: 100%.